Skip to main content

Alpha Tau Medical Ltd.

DRTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001871321

In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 4 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.1M in total; ARK Invest is the only superinvestor holding it.

Other share classesDRTSW

Q3 2022 vs. Q2 2022

How the institutions holding Alpha Tau Medical Ltd. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of DRTS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders1418+4
Shares653.7K697.3K+43.7K (+6.7%)
Value$5.92M$4.01M−$1.91M (−32.2%)

New holders (9)

Institutions that held Alpha Tau Medical Ltd. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to DRTS in Q3 2022
InstitutionSharesValue% of portfolio
Citigroup Inc29,718$174.0K0.00%
Wealthspire Advisors, LLC22,632$132.0K0.00%
Renaissance Technologies LLC19,016$111.0K0.00%
Wells Fargo & Company10,806$63.0K0.00%
Financial Guidance Group, Inc.10,260$60.0K0.05%
Tower Research Capital LLC (TRC)6,269$37.0K0.00%
Tower View Investment Management & Research LLC5,566$33.0K0.03%
Tuttle Tactical Management10,778$5.00K0.02%
Highbridge Capital Management LLC60$00.00%

Sold out (5)

Institutions that held Alpha Tau Medical Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of DRTS in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Ergoteles LLC30,266$273.0K
HSBC Holdings PLC16,000$148.0K
Barclays PLC16,000$144.0K
Penserra Capital Management LLC2,328$20.0K
UBS Group AG1,916$17.0K